Publications
Detailed Information
TNF-alpha inhibits the CD3-mediated upregulation of voltage-gated K(+) channel (K(v)1.3) in human T cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pang, Bo | - |
dc.contributor.author | Zheng, Haifeng | - |
dc.contributor.author | Jung, Kyeong Cheon | - |
dc.contributor.author | Shin, Dong Hoon | - |
dc.contributor.author | Ko, Jae Hong | - |
dc.contributor.author | Kang, Tong Mook | - |
dc.contributor.author | Kim, Sung Joon | - |
dc.contributor.author | Lee, Ki Young | - |
dc.date.accessioned | 2012-05-22T06:11:51Z | - |
dc.date.available | 2012-05-22T06:11:51Z | - |
dc.date.issued | 2010-01-01 | - |
dc.identifier.citation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Vol.391 1; 909-914 | ko_KR |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://hdl.handle.net/10371/76236 | - |
dc.description.abstract | A long term treatment of T cells with tumor necrosis factor alpha (TNF-alpha) paradoxically inhibits the immunologic responses to TCR/CD3 stimulation. The voltage-gated K(+) channels (K(v)) of T cells attracted attention as a pharmacological target for the treatment of autoimmune diseases. Here. the authors Investigated the effects of TNF-alpha on the K(v) current (I(Kv)) and its upregulation by CD3 in human T cells Acute treatment with TNF-alpha (10 min) temporarily decreased I(Kv) in Jurkat-T cells (cells subsequently recovered after treatment >12 h) whereas CD3 stimulation for 24 h increased I(Kv) amplitude more than two-fold Furthermore, chronic pretreatment with TNF-alpha almost completely blocked the I(Kv) increase induced by CD3 stimulation. An immunoblot study confirmed an increase in the protein level of K(v) induced by CD3 stimulation, and its inhibition by TNF-alpha pretreatment. In addition, the facilitation of I(Kv) by CD3 stimulation and its inhibition by pretreatment with TNF-alpha were confirmed in freshly isolated human peripheral CD4(+) T cells. in which the voltage-dependence of I(Kv) was unaffected by TNF-alpha and/or CD3 stimulation. We conclude that the inhibition of CD3-induced K(v) upregulation by TNF-alpha might be associated with the paradoxical Suppression of T cell function by TNF-alpha. under conditions of chronic inflammation. (C) 2009 Elsevier Inc. All rights reserved | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | ko_KR |
dc.subject | TNF-alpha | ko_KR |
dc.subject | T cell | ko_KR |
dc.subject | CD3 | ko_KR |
dc.subject | K(v)1.3 | ko_KR |
dc.subject | K(+) channel | ko_KR |
dc.title | TNF-alpha inhibits the CD3-mediated upregulation of voltage-gated K(+) channel (K(v)1.3) in human T cells | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 신동훈 | - |
dc.contributor.AlternativeAuthor | 강동묵 | - |
dc.contributor.AlternativeAuthor | 김성준 | - |
dc.contributor.AlternativeAuthor | 이기영 | - |
dc.contributor.AlternativeAuthor | 정경천 | - |
dc.contributor.AlternativeAuthor | 고재홍 | - |
dc.identifier.doi | 10.1016/j.bbrc.2009.11.162 | - |
dc.citation.journaltitle | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.description.citedreference | Church LD, 2005, FEBS LETT, V579, P1539, DOI 10.1016/j.febslet.2005.01.051 | - |
dc.description.citedreference | He HT, 2005, SEMIN IMMUNOL, V17, P23, DOI 10.1016/j.smim.2004.09.001 | - |
dc.description.citedreference | Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020 | - |
dc.description.citedreference | Clark JM, 2004, P NATL ACAD SCI USA, V101, P1696, DOI 10.1073/pnas.0308231100 | - |
dc.description.citedreference | Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100 | - |
dc.description.citedreference | Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921 | - |
dc.description.citedreference | Isomaki P, 2001, J IMMUNOL, V166, P5495 | - |
dc.description.citedreference | Levite M, 2000, J EXP MED, V191, P1167 | - |
dc.description.citedreference | Hoessli DC, 2000, GLYCOCONJUGATE J, V17, P191 | - |
dc.description.citedreference | Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193 | - |
dc.description.citedreference | Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102 | - |
dc.description.citedreference | Schwarz EC, 2007, EUR J IMMUNOL, V37, P2723, DOI 10.1002/eji.200737039 | - |
dc.description.citedreference | Lee LF, 2008, P NATL ACAD SCI USA, V105, P10107, DOI 10.1073/pnas.0803336105 | - |
dc.description.citedreference | Cope AP, 1998, CURR OPIN IMMUNOL, V10, P669 | - |
dc.description.citedreference | Liu KQ, 1998, J EXP MED, V187, P1721 | - |
dc.description.citedreference | Liu JL, 1998, NAT MED, V4, P78 | - |
dc.description.citedreference | Cope AP, 1997, J EXP MED, V185, P1573 | - |
dc.description.citedreference | Chung I, 1997, J MEMBRANE BIOL, V156, P73 | - |
dc.description.citedreference | Zhou T, 1996, J IMMUNOL, V156, P2661 | - |
dc.description.citedreference | LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623 | - |
dc.description.citedreference | MAKAR RSJ, 1994, J LIPID RES, V35, P1888 | - |
dc.description.citedreference | COPE AP, 1994, J CLIN INVEST, V94, P749 | - |
dc.description.citedreference | LIN CS, 1993, J EXP MED, V177, P637 | - |
dc.description.citedreference | LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094 | - |
dc.description.citedreference | BIRX DL, 1984, J IMMUNOL, V133, P2904 | - |
dc.description.citedreference | CHANDY KG, 1984, J EXP MED, V160, P369 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.